|
Video: What is a Stock Split?
|
|
TELA Bio is a medical technology company focused on providing soft-tissue reconstruction solutions that support clinical outcomes by focusing on the preservation and restoration of the patient's own anatomy. Co.'s first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), engages in hernia repair and abdominal wall reconstruction by combining the benefits of biologic matrices and polymer materials. In addition, Co. has also designed an OviTex product specifically for use in laparoscopic and robotic-assisted hernia repair, which it markets as OviTex LPR. Co.'s second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, engages in plastic and reconstructive surgery. According to our TELA Bio stock split history records, TELA Bio has had 1 split. | |
|
TELA Bio (TELA) has 1 split in our TELA Bio stock split history database. The split for TELA took place on November 14, 2002. This was a 1 for 25 reverse split, meaning for each 25 shares of TELA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 40 share position following the split.
When a company such as TELA Bio conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the TELA Bio stock split history from start to finish, an original position size of 1000 shares would have turned into 40 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into TELA Bio shares, starting with a $10,000 purchase of TELA, presented on a split-history-adjusted basis factoring in the complete TELA Bio stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/11/2019 |
|
End date: |
04/23/2024 |
|
Start price/share: |
$12.85 |
|
End price/share: |
$4.47 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-65.21% |
|
Average Annual Total Return: |
-21.13% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3,477.99 |
|
Years: |
4.45 |
|
|
|
Date |
Ratio |
11/14/2002 | 1 for 25 |
|
|